Holen Sie sich die Stockscreener-App
2.58
1.91%
-0.04
Schlusskurs vom Vortag:
$2.62
Offen:
$2.62
24-Stunden-Volumen:
5,427
Relative Volume:
0.05
Marktkapitalisierung:
$1.45B
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-22.36%
1M Leistung:
-3.75%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.55
$2.62
1-Wochen-Bereich:
$2.55
$3.30
52-Wochen-Spanne:
$2.51
$6.25
Sl Science Holding Ltd Stock (SLBT) Company Profile
Firmenname
Sl Science Holding Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare SLBT vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLBT
Sl Science Holding Ltd
|
2.59 | 1.47B | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
523.85 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
801.77 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
997.97 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
138.19 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
208.32 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Sl Science Holding Ltd Aktie (SLBT) Neueste Nachrichten
SL Science Holding Ltd (SLBT) Live Share Price, Invest From India - INDmoney
Morning Market Movers: RARE, BIAF, TLYS, SNOW See Big Swings - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
NetApp, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session - Benzinga
Why Snowflake Shares Are Trading Higher By Over 24%; Here Are 20 Stocks Moving Premarket - Benzinga
SL Science Rings Nasdaq Bell, Marks First Quarter as Public Company and Advances γδ T Cell Therapy Platform - quiverquant.com
Johnson Lau Steps Down as VP of Finance at SL Science Holding Ltd - kalkinemedia.com
SL Science Holding Discloses Resignation of Vice President of Finance - TipRanks
SL Science (SLBT) finance VP steps down with no insider trades - Stock Titan
SL Science (SLBT) finance VP to step down Aug. 31 - Stock Titan
SL Science licensor files exosome drug master file with FDA - Investing.com India
SL Science Highlights New FDA Drug Master File for GDT Cell-Derived Exosomes, Expanding the Regulatory Foundation of its Platform - The Manila Times
A new FDA filing covers exosomes; studies indicate they can cross the blood-brain barrier - Stock Titan
SL Science Holding Ltd Switches Audit Firm to TAAD LLP in Late August 2026 - TipRanks
SL Science Holding Limited Ordinary Shares (NASDAQ: SLBT) Stock Price, News & Analysis - Kalkine
SL Science Holding (SLBT) Stock May Be Fully Priced Even After A 74% Fall - Yahoo Finance
SL Science Holding Ord Shs (SLBT) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
SL Science Holding Ltd SEC Filing (Aug 13, 2026) - Stock Titan
Upcoming & Recent IPO'sIPOs Calendar - Yahoo Finance
RBGLY Stock Price and Chart — OTC:RBGLY - TradingView
SL Science Leadership Co-Authors Peer-Reviewed Framework for Clinical Development of γδ T Cell Therapy in Glioblastoma - The Manila Times
SL Science Holding Limited Announces Publication of Peer-Reviewed Framework for γδ T Cell Therapy in Glioblastoma - Quiver Quantitative
Brain Cancer Cell Therapy Trials Must Track Cells, Review Says - Stock Titan
AbCellera Stock Soars 30% After Menopause Drug ABCL635 Hits Phase 2 Success In Hot Flash Trial Results - International Business Times Australia
Upcoming and recent IPOs – IPOs calendar - Yahoo Finance UK
Operating expenses (excl. COGS) of SL Science Holding Limited – NASDAQ:SLBT - TradingView
SL Science Holding Ord Shs (SLBT) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
SL Science Holding (NASDAQ: SLBT) files to register resale of 1.04M shares - Stock Titan
Saol Therapeutics Announces the Acceptance of Resubmission of SL1009 (DCA) by the FDA with PDUFA Date of Dec. 30, 2026 - Yahoo Finance
SL Science Holding Ord Shs (SLBT) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
SLBT|SL Science Holding Ord Shs|Price:3.200|Chg%:+0.555 - TradingKey
SL Science Holding Ord Shs (SLBT) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
SL Science Holding Ord Shs (SLBT) Cash Flow - TradingKey
SL Science Holding Ord Shs (SLBT) Valuation: PE, PB & Fair Value Analysis - TradingKey
SL Science Holding Ord Shs (SLBT) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - tradingkey.com
Kwo Liang Chen Net Worth (2026) - GuruFocus
SLBT|SL Science Holding Ord Shs|Price:3.120|Chg%:-0.050 - TradingKey
SLBT|SL Science Holding Ord Shs|Price:2.620|Chg%:-0.500 - TradingKey
Ching Dong Wang Net Worth (2026) - GuruFocus
Mingche Liu Net Worth (2026) - GuruFocus
The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading? - Yahoo Finance
Lok Sang Leung Net Worth (2026) - GuruFocus
SL Science presents glioblastoma treatment data at WCP 2026 - Investing.com UK
SL Science presents glioblastoma treatment data at WCP 2026 By Investing.com - Investing.com South Africa
Trevi Therapeutics Shares Surge 13% as Biopharma Investors Cheer Cough Drug Data at London Conference - International Business Times Australia
SL Science Holding Limited Exhibits Breakthrough Gamma Delta T Cell Therapy for Glioblastoma at 2026 World Congress of Basic and Clinical Pharmacology - marketscreener.com
SL Science Announces Successful Exhibition of Breakthrough Brain Cancer Therapy Research at the 2026 World Congress of Basic and Clinical Pharmacology - The Manila Times
SL Science Showcases Preclinical Gamma Delta T Cell Study Demonstrating Glioblastoma Elimination at WCP 2026 - Quiver Quantitative
Preclinical γδ T cells eradicated a brain tumor by day 26 at highest dose - Stock Titan
4DMedical Shares Plunge 15.57% to $3.20 as Volatile ASX Healthcare Stock's Wild Ride Continues This Week - International Business Times Australia
Finanzdaten der Sl Science Holding Ltd-Aktie (SLBT)
Es liegen keine Finanzdaten für Sl Science Holding Ltd (SLBT) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):